We are live on ! Find out more
ERNA icon

Ernexa Therapeutics

3 hedge funds and large institutions have $1.84M invested in Ernexa Therapeutics in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 3 → 3 (0)

0.16% less ownership

Funds ownership: 7.43% → 7.26% (-0.16%)

100% less capital inflows, than outflows

Capital inflows: $0 | Capital outflows: $12K

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$12K

ERNA Hedge Fund Activity: Q3 2013 in Review

3 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Ernexa Therapeutics (ERNA) for Q3 2013, worth a combined $1.84M — down 15% from $2.18M a quarter earlier.

Fund positioning in ERNA was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

The largest seller was Citadel Advisors, cutting an estimated $12K.

  • 3 institutional investors held Ernexa Therapeutics (ERNA) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $1.84M of Ernexa Therapeutics stock for Q3 2013, down 15% quarter-over-quarter.
  • 0 funds opened new Ernexa Therapeutics positions in Q3 2013 and 0 closed out.
  • The largest Ernexa Therapeutics seller in Q3 2013 was Citadel Advisors, an estimated $12K sold.

Based on aggregated 13F filings for Q3 2013.